AbbVie Biotherapeutics Inc.;Dana-Farber Cancer Institute, Inc.
发明人:
Afar, Daniel,Andersen, Kenneth C.,Tai, Yu-Tzu
申请号：
HRP20161284
公开号：
HRP20161284T1
申请日:
2016.10.06
申请国别(地区):
HR
年份:
2016
代理人:
摘要：
Composition suitable for treating multiple myeloma in a subject, comprising a therapeutically effective amount of HuLuc63, a therapeutically effective amount of bortezomib, and a pharmaceutically acceptable carrier, wherein said composition is capable of being administered in a single or multiple dose regimen.
